IMT 504

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIMT 504
Drug Alias NameImmunostimulatory oligonucleotide (Immunotech)IMT-504
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsDiabetes MellitusNeuralgiaOsteoporosis +[8
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunotech SAS
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsNeuralgiaOsteoporosisBreast Neoplasms +[7

Other Information

ATC CodeN/A
Related LinksN/A